The immunotherapy of Alzheimer's disease
<p>Abstract</p> <p>Only a small percentage of patients with Alzheimer's disease benefit from current drug therapy and for only a relatively short time. This is not surprising as the goal of these drugs is to enhance existing cerebral function in Alzheimer patients and not to b...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2004-11-01
|
| Series: | Immunity & Ageing |
| Online Access: | http://www.immunityageing.com/content/1/1/2 |